[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339423-105":59,"doc-detail-339423-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","visfatin-facilitates-vegf-d-induced-lymphangiogenesis-through-activating-hif-1-and-suppressing-mir-2277-3p-in-human-chondrosarcoma-research-abstract","Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma - Research Abstract","","Chondrosarcoma is a malignant bone tumor linked to lung metastases, and lymphangiogenesis is a key driver of cancer spread. Visfatin, an adipokine associated with enhanced metastasis, was investigated for its relationship with VEGF-D signaling and lymphangiogenesis in chondrosarcoma. Clinical samples show elevated VEGF-D in patients. Visfatin stimulation promotes VEGF-D-dependent lymphangiogenesis in lymphatic endothelial cells, inducing VEGF-D via HIF-1α activation and lowering miR-2277-3p through Raf/MEK/ERK signaling. In vivo, visfatin regulates chondrosarcoma-related lymphangiogenesis, supporting it as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/visfatin-facilitates-vegf-d-induced-lymphangiogenesis-through-activating-hif-1-and-suppressing-mir-2277-3p-in-human-chondrosarcoma-research-abstract/339423/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/visfatin-facilitates-vegf-d-induced-lymphangiogenesis-through-activating-hif-1-and-suppressing-mir-2277-3p-in-human-chondrosarcoma-research-abstract/339423.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main focus regarding chondrosarcoma?","Question",{"text":112,"@type":113},"The study examines how visfatin affects VEGF-D generation and lymphangiogenesis in human chondrosarcoma, and how this may contribute to metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do patient samples relate to the VEGF-D findings?",{"text":117,"@type":113},"The results from clinical samples show VEGF-D levels are markedly higher in chondrosarcoma patients than in normal individuals.",{"name":119,"@type":110,"acceptedAnswer":120},"Through which pathways does visfatin regulate lymphangiogenesis?",{"text":121,"@type":113},"Visfatin induces VEGF-D production by activating HIF-1α and suppressing miR-2277-3p via the Raf/MEK/ERK signaling cascade, leading to VEGF-D-dependent lymphangiogenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339423,1790155990,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Article  \nVisfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma  \nChang-Yu Song 1,†, Shang-Lin Hsieh 1,2,†, Shang-Yu Yang 3, Chih-Yang Lin 4, Shih-Wei Wang 5,6, Chun-Hao Tsai 7,8, Yuan-Shun Lo 8,9,10, Yi-Chin Fong 7,8,9 and Chih-Hsin Tang 1,3,11,12,13, *  \nCitation: Song, C.-Y.; Hsieh, S.-L.; Yang, S.-Y.; Lin, C.-Y.; Wang, S.-W.; Tsai, C.-H.; Lo, Y.-S.; Fong, Y.-C.; Tang, C.-H. Visfatin Facilitates  \nVEGF-D-Induced Lymphangiogenesis through Activating HIF-1 α and Suppressing miR-2277-3p in Human Chondrosarcoma. Int. J. Mol. Sci. 2024, 25, 5142. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25105142  \nAcademic Editor: Dominique Heymann  \nReceived: 2 April 2024  \nRevised: 7 May 2024  \nAccepted: 8 May 2024  \nPublished: 9 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Graduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan; [zxcb983513@gmail.com](zxcb983513@gmail.com) (C.-Y.S.); [neosolomon@msn.com](neosolomon@msn.com) (S.-L.H.)  \n2 Minimally Invasive Spine and Joint Center, Buddhist Tzu Chi General Hospital Taichung Branch,  \nTaichung 42721, Taiwan  \n3 Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan; [henry879019@asia.edu.tw](henry879019@asia.edu.tw)  \n4 Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 11104, Taiwan; [p123400@hotmail.com](p123400@hotmail.com)  \n5 Institute of Biomedical Sciences, Mackay Medical College, New Taipei City 25245, Taiwan; [shihwei@mmc.edu.tw](shihwei@mmc.edu.tw)  \n6 Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan  \n7 Department of Sports Medicine, College of Health Care, China Medical University, Taichung 40432, Taiwan; [ritsai8615@gmail.com](ritsai8615@gmail.com) (C.-H.T.); yichin.fong@msa.hinet.net (Y.-C.F.)  \n8 Department of Orthopedic Surgery, China Medical University Hospital, Taichung 40432, Taiwan; [yuanshunlo@gmail.com](yuanshunlo@gmail.com)  \n9 Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin 65101, Taiwan  \n10 Graduate Institute of Precision Engineering, National Chung Hsing University, Taichung 40227, Taiwan  \n11 Department of Pharmacology, School of Medicine, China Medical University, Taichung 40402, Taiwan  \n12 Chinese Medicine Research Center, China Medical University, Taichung 40402, Taiwan  \n13 Department of Medical Research, China Medical University Hsinchu Hospital, Hsinchu 30205, Taiwan  \n* Correspondence: [chtang@mail.cmu.edu.tw](chtang@mail.cmu.edu.tw)[ ](chtang@mail.cmu.edu.tw)† These authors contributed equally to this work.  \nAbstract: Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous tissue and is associated with lung metastases. Lymphangiogenesis plays an essential role in cancer metastasis. Visfatin is an adipokine reported to enhance tumor metastasis, but its relationship with VEGF-D generation and lymphangiogenesis in chondrosarcoma remains undetermined. Our results from clinical samples reveal that VEGF-D levels are markedly higher in chondrosarcoma patients than in normal individuals. Visfatin stimulation promotes VEGF-D-dependent lymphatic endothelial cell lymphangiogenesis. We also found that visfatin induces VEGF-D production by activating HIF-1α and reducing miR-2277-3p generation through the Raf/MEK/ERK signaling cascade. Importantly, visfatin controls chondrosarcoma-related lymphangiogenesis in vivo. Therefore, visfatin is a promising target in the treatment of chondrosarcoma lymphangiogenesis.  \nKeywords: chondrosar","cbCainUL2MQfvzqr","https://ap.wps.com/l/cbCainUL2MQfvzqr","pdf",10108448,14,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main focus regarding chondrosarcoma?\",\"answer\":\"The study examines how visfatin affects VEGF-D generation and lymphangiogenesis in human chondrosarcoma, and how this may contribute to metastasis.\"},{\"question\":\"How do patient samples relate to the VEGF-D findings?\",\"answer\":\"The results from clinical samples show VEGF-D levels are markedly higher in chondrosarcoma patients than in normal individuals.\"},{\"question\":\"Through which pathways does visfatin regulate lymphangiogenesis?\",\"answer\":\"Visfatin induces VEGF-D production by activating HIF-1α and suppressing miR-2277-3p via the Raf/MEK/ERK signaling cascade, leading to VEGF-D-dependent lymphangiogenesis.\"}]","Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma - Research Abstract | PDF",1790030220,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/657f2fa59979ceb760d09fb0ae73b810.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/929b6ffb03b2af6968ee11b634500deb.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23ba3134647f41f34091167a25a11b9a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09b4cb00112112379f20bad6620a9095.webp",980,1385]